Drugs and Pharmaceuticals

381 articles:
Pharma
Antibiotics
Anticoagulation
SGLT2 inhibitors
Tranexamic Acid
Psilocybin
Biologic Therapies
Insulin
by Maddi Dellplain

Feeling blue? It’s not just you. Canadians live in a ‘winter depression hotspot’

Seasonal affective disorder or – the appropriately acronymic SAD –  will impact an estimated 15 per cent of Canadians during their lifetime.
by Helen Rubtsov

‘How would the average Canadian know to ask?’ Men left in the dark on minimally invasive prostate cancer treatments

For many men, prostate cancer is not just a question of survival. It is a question of how they will live afterward. When the system fails to offer a full picture of the options available, it limits not only their choices but their long-term well-being.
by Miranda Schreiber

‘Things went horribly wrong’: Patient advocates spreading the word about dangers of Botox

Much of the conversation about Botox centres on whether it looks good or bad, or if getting it can be considered a “feminist” choice. Less attention has been given to the fact that research indicates that one in six patients who are injected with Botox experiences adverse effects from the procedure.
by Mona Samani Savana Elsays Peter Zhang

Pharmacists are essential in bridging the gap between AI and patient-centered care

In a world pushing toward data-driven systems and algorithms, pharmacists can safeguard the human element of care by acting as a nexus between health and technology.
by Homira Osman Stacey Lintern Danielle Campo McLeod

Fail-first drug rules defy logic, deny timely access for people with rare diseases

Despite the recent approval of targeted biologics that can significantly improve quality of life, Canadians living with Myasthenia Gravis continue to face unjust policy barriers.

by Hanan Hammad

Needle phobic? Nasal spray flu vaccine allays fear but has limited access in Canada

Canadians who avoid the flu shot because they fear needles have an alternative that won’t make them hold their breath until it’s over. But availability may pose a problem for access.

by Muneeb Ahmed

Three tools clinicians use to debunk viral health myths

Canadians face a steady stream of confident health claims; some partly right, others wrong and risky – and some potentially fatal. Health care experts share some best practices to combat myths in clinic.

by Callia Georgoulis

Barbie has an insulin pump and CGM too: Why representation in chronic illness education matters

I never had a Barbie with dark hair, brown eyes and an insulin pump when I was growing up. But today’s girls can. And that is progress worth celebrating.
by Jackie Tsang Susan Dong

Tylenol misinformation puts pregnant patients at risk

Casting doubt on Tylenol without solid evidence does not empower pregnant people, it corners them. It adds guilt, stigma and undermines their confidence in making safe decisions for themselves and their babies.
by Alex Hoagland

Empowering pharmacists is about more than saving emergency departments – it’s about equity in health care

Not only did Ontario's move to allow pharmacists to prescribe for certain minor ailments reduce ED strain, but it also reduced inequities in access to care.

by Geoffrey M. Pradella

Expanding access to disability supports: the case for impact investing

Thanks to limited access to interventions and income thresholds that fail to account for the cost of caregiving, families with children with neurodevelopmental disabilities are often left to pay out-of-pocket for services.
by Linxi Mytkolli

Trust those who heal, not those who provoke

A Seuss-style rhyme on the very real harm of health misinformation.
by Abigail Jaimes Zelaya

Black mistrust is logical and rational: What public health policymakers must learn from Black communities

Black communities are not hesitant just for the sake of it. They are hesitant because of memory. They need structural change built from trust, not just crisis.
by Matthew Cho

When patients ask about psychedelics

Over the past decade, scientific interest in psychedelics such as psilocybin and MDMA has risen, along with recreational use. This has put physicians in a difficult place – one our medical training has not prepared us for.
by AnnMarie Churchill Marion Cooper

Rethinking mental health and substance use health solutions

What if you or someone you know needs mental health and substance use health care right now? Do you know exactly where to go to get what you need?
by Tushar Sood

‘And the dead cannot recover’: The fatal consequences of closing Supervised Consumption Sites

Bill 223 ordered the closure of more than half of Ontario’s 17 supervised consumption sites with no equivalent replacement. For many medical students like me, this is personal.

by Charissa Egger

The MS treatment gap: How costs and outdated policies limit care in Canada

Early, aggressive treatment can significantly improve outcomes for people living with MS. But provinces have yet to implement coverage policies that would ensure patients receive optimal care.

by Homira Osman Stacey Lintern Danielle Campo McLeod

Approved but denied: Canadians with neuromuscular diseases face unequal access to treatment

We are told health care in Canada is equal for everyone. But it is not. Particularly for patients with neuromuscular diseases, what you get depends on where you live.
by Nilah Ahimsadasan

When care doesn’t translate

For South Asian communities, improved care means earlier screening, culturally relevant guidance and meaningful language access. Without these changes, we risk continuing a pattern of preventable harm.
by Lisa Dolovich

Better together: Where are the pharmacists in Ontario’s primary care plan?

We have said it before. We will say it again. Pharmacists in Ontario are well-prepared for an expanded role in our health-care system.

1 of 20